Company / R&D Expense
Genprex, Inc. R&D Expense History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$17.6M
FY2024
5-year range
$289.9K / $17.6M
FY2020-FY2024
Trend
+53.1%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has increased for 4 consecutive years, from $289,934 in FY2018 to $18M in FY2024.
Based on SEC 10-K filings.
$18M in FY2024 with a 3-year CAGR of +34.1%.
Improved from $9M to $18M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +34.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Genprex, Inc.'s r&d expense has grown for 4 consecutive years.
- 3-year CAGR of +34.1%, indicating consistent growth.
- In FY2024, r&d expense increased 53.1% year-over-year.
- Lowest r&d expense in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -24.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $17.6M | +53.1% |
| FY2023 | $11.5M | +28.3% |
| FY2022 | $9.0M | +22.8% |
| FY2021 | $7.3M | +2418.8% |
| FY2018 | $289.9K | -18.3% |
| FY2017 | $354.9K | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026